Abstract
This paper uses John Rawls' theory of justice to defend the patent system against charges that it has an unfair effect on access to medications, from the perspective of national and international justice. The paper argues that the patent system is fair in a national context because it respects intellectual property rights and it benefits the least advantaged members of society by providing incentives for inventors, investors, and entrepreneurs. The paper also argues that the patent system is fair in an international context, provided that developed nations take steps to help disease-stricken countries secure internal justice. Fairness in a national or international context also requires that the patent system should include emergency exceptions to deal with short-term inequities.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Angell, M. (2000) The Pharmaceutical Industry—To Whom is it Accountable? The New England Journal of Medicine 342, 1902–1904.
Beitz, C. (1998) International Justice: Conflict. In R. Chadwick, (Ed.), Encyclopedia of Applied Ethics (Vol. 2), pp. 871–874. New York: Academic.
Beitz, C. (1999) Political Theory and International Relations, (2nd ed.). Princeton, NJ: Princeton University Press.
Best-Online Pharmacy.com. (2003) Amoxycillin. Available at: http://www.best-online-pharmacies. com/prescription-drugs/prescription-drugs-amoxycillin.html
Bian, T. (1997) The Drug Lords: America's Pharmaceutical Cartel. New York: No Barriers.
Bildt, C. (2003, January 7) Fight Poverty, Not Patents. The Wall Street Journal, p. A13.
Blustein, P. (2003, February 1) Activists Hail President's Call for More Funding to Fight AIDS. The Washington Post, pp. A12.
Bodenheimer, T. (2000) Uneasy Alliance: Clinical Investigators and the Pharmaceutical Industry. The New England Journal of Medicine 342, 1539–1544.
Brody, B. (1995) Ethical Issues in Drug Testing, Approval, and Pricing. New York: Oxford University Press.
Brody, B. (1996) Public Goods and Fair Prices: Balancing Technological Innovation and Social Well Being. Hastings Center Report 26(2), 5–11.
Daniels, N. (1984) Just Health Care. Cambridge, UK: Cambridge University Press.
Diller, L. (1996) The Run on Ritalin: Attention Deficit Disorder and Stimulant Treatment in the 1990s. Hastings Center Report 26(2), 12–18.
Dworkin, G. (1988) The Theory and Practice of Autonomy. Cambridge, UK: Cambridge University Press.
Enserink, M. (2003) Bill Gates Plans a Hit List, with NIH's Help. Science 299, 641.
Goldhammer, A. (2001) Current Issues in Clinical Research and the Development of New Pharmaceu-ticals. Accountability in Research 8, 283–291.
Gutmann, A., and Thompson, D. (1996) Democracy and Disagreement. Cambridge, MA: Harvard University Press.
Harsanyi, J. (1975) Can the Maximin Principle Serve as a Basis for Morality? American Political Science Review 69, 594–606.
Harsanyi, J. (1976) Essays on Ethics, Social Behavior, and Scientific Explanation. Dordrecht, The Netherlands: Reidel.
Headden, S. (1997, September 1) The Big Pill Push. U.S. News and World Report, pp. 67–71.
Hewitt, W. (1967) Penicillin: Historical Impact on Infection Control. Annals of the New York Academy of Sciences 145, 212–215
King, R. (1997, Winter/Spring) The Evolution of Today's Calculator. International Calculator Col-lector 15/16, p. 1, 4. Available at: http://www.vintagecalculators.com/html/evolutionoftoday's-calculato. html
Lacayo, A. (2003) Seeking a Balance: International Pharmaceutical Patent Protection, Public Health Crises, and the Emerging Threat of Bio-terrorism. University of Miami International-American Law Review 33, 295–321.
Loff, B. (2002) World Trade Organization Wrestles with Access to Cheap Drugs Solution. The Lancet 360, 1670.
Manzer, J. (2002) Is Canada American's Favorite Drugstore? Medical Post 38(46), 1–5.
Marsa, L. (1999) Prescription for Profits: How the Pharmaceutical Industry Bankrolled the Unholy Marriage Between Science and Business. New York: Scribner. Mill, J.S. (1861 [1979]) Utilitari-anism. Indianapolis, IN: Hackett.
Miller, A., and Davis, M. (2000) Intellectual Property. St. Paul, MN: West.
Nerozzi, M. (2002) The Battle Over Life-Saving Pharmaceuticals: Are Developing Countries Being ‘TRIPped’ by Developed Countries? Villanova Law Review 47, 605–641.
Nozick, R. (1974) Anarchy, State, and Utopia. New York: Basic.
Obsolete Technology Website. (2003) Apple III. Available at: http://oldcomputers.net/appleiii.html
O'Neill, O. (1998) International Justice: Distribution. In R. Chadwick, (Ed.)., Encyclopedia of Applied Ethics, (Vol. 2), pp. 874–877. New York: Academic.
Pear, R. (2002, December 25) Law Requiring Lower Drug Prices in Struck Down. The New York Times, p. A1.
Pear, R. (2003, January 3) Bush May Link Drug Benefit in Medicare to Private Plans. The New York Times,p.A1.
Pharmaceutical Research and Manufacturing Association (PhRMA). (2003a) Research and Develop-ment. Washington, DC: PhRMA. Available at: www.phrma.org
Pharmaceutical Research and Manufacturing Association (PhRMA). (2003b) Intellectual Property. Washington, DC: PhRMA. Available at: www.phrma.org
Plato. (1974 [circa 400 BC]) The Republic. (G. Grube, (transl). Indianapolis, IN: Hackett.
Rawls, J. (1971) A Theory of Justice. Cambridge, MA: Harvard University Press.
Rawls, J. (1993) Political Liberalism. New York: Columbia University Press.
Rawls, J. (1999) The Law of the Peoples. Cambridge, MA: Harvard University Press.
Rawls, J. (2002) Justice As Fairness: A Restatement. E. Kelly, (Ed.). Cambridge, MA: Harvard Uni-versity Press.
Reich, M. (2000) The Global Drug Gap. Science 287, 1979–1981.
Resnik, D. (2001) Developing Drugs for the Developing World: An Economic, Legal, Moral, and Political Dilemma. Developing World Bioethics 1,11–32.
Resnik, D., and De Ville, K. (2002) Bioterrorism and Patent Rights: Compulsory Licensure and the Case of Cipro. American Journal of Bioethics 2(3), 29–39.
Resnik, M. (1987) Choice: An Introduction to Decision Theory. Minneapolis: University of Minnesota Press.
Samuelson, P. (1980) Economics (11th ed.). New York: McGraw-Hill.
Sandel, M. (1982) Liberalism and the Limits of Justice. Cambridge, UK: Cambridge University Press.
Schaafsma, P. (1997) An Economic Overview of Patents. Journal of the Patent and Trademark Office Society 79, 241–257.
Shamoo, A., and Resnik, D. (2002) Responsible Conduct of Research. New York: Oxford University Press.
Singer, P. (1972) Famine, Affluence, and Morality. Philosophy and Public Affairs 1, 229–243.
Stolberg, S. (2003, February 2) The White House Gets Religion on AIDS in Africa. The New York Times,p.A1.
Stolberg, S., and Gerth, J. (2000, April 23) Medicine Merchants: Holding Down the Competition. The New York Times,p.A1.
U.S. Constitution. (1787) Article 1, Section 8, Clause 8.
Wreen, M. (1998) Patents. In R. Chadwick, (Ed.), Encyclopedia of Applied Ethics (Vol. 3), New York: Academic. pp. 435–447.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Resnik, D.B. Fair Drug Prices and the Patent System. Health Care Analysis 12, 91–115 (2004). https://doi.org/10.1023/B:HCAN.0000041185.52817.8c
Issue Date:
DOI: https://doi.org/10.1023/B:HCAN.0000041185.52817.8c